| # | Drug | Count |
|---|---|---|
| 0 | ETOPOSIDE | 16 |
| 1 | METHOTREXATE SODIUM | 13 |
| 2 | CYCLOPHOSPHAMIDE | 12 |
| 3 | CYCLOPHOSPHAMIDE FOR INJECTION | 12 |
| 4 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 12 |
| 5 | METHOTREXATE | 12 |
| 6 | CISPLATIN | 9 |
| 7 | CYTARABINE | 9 |
| 8 | VORICONAZOLE | 9 |
| 9 | AZATHIOPRINE | 8 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | GRANULOCYTE COLONY STIMULATING FACTOR | 8 | 0.0037 |
| 1 | OLOPATADINE HCL | 1 | 0.0027 |
| 2 | PURIXAN | 1 | 0.0013 |
| 3 | RYDAPT | 2 | 0.0010 |
| 4 | MICAFUNGIN SODIUM | 6 | 0.0009 |
| 5 | TOBRAMYCIN AND DEXAMETHASONE | 3 | 0.0009 |
| 6 | FLURBIPROFEN | 1 | 0.0007 |
| 7 | MITOXANTRONE HYDROCHLORIDE | 3 | 0.0005 |
| 8 | (DAUNORUBICIN AND CYTARABINE) LIPOSOME | 1 | 0.0004 |
| 9 | THIOTEPA | 4 | 0.0004 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 20 |
| 1 | Platinum-based Drug [EPC] | 18 |
| 2 | Alkylating Drug [EPC] | 16 |
| 3 | Nucleoside Metabolic Inhibitor [EPC] | 16 |
| 4 | Topoisomerase Inhibitor [EPC] | 16 |
| 5 | Azole Antifungal [EPC] | 15 |
| 6 | Folate Analog Metabolic Inhibitor [EPC] | 12 |
| 7 | Purine Antimetabolite [EPC] | 8 |
| 8 | Echinocandin Antifungal [EPC] | 6 |
| 9 | Fluoroquinolone Antibacterial [EPC] | 6 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Echinocandin Antifungal [EPC] | 6 | 0.0007 |
| 1 | Anthracycline Topoisomerase Inhibitor [EPC] | 1 | 0.0004 |
| 2 | CD33-directed Immunoconjugate [EPC] | 1 | 0.0003 |
| 3 | Lipid-based Polyene Antifungal [EPC] | 3 | 0.0002 |
| 4 | Topoisomerase Inhibitor [EPC] | 16 | 0.0002 |
| 5 | Azole Antifungal [EPC] | 15 | 0.0001 |
| 6 | Aminoglycoside Antibacterial [EPC] | 4 | 0.0001 |
| 7 | Purine Antimetabolite [EPC] | 8 | 0.0001 |
| 8 | BCL-2 Inhibitor [EPC] | 5 | 0.0001 |
| 9 | Asparagine-specific Enzyme [EPC] | 1 | 0.0001 |